Anideep Eye Hospital And Institute Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 28-12-2024
- Paid Up Capital ₹ 2.50 M
as on 28-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 26.58 Cr
as on 28-12-2024
- Revenue 41.56%
(FY 2022)
- Profit 182.47%
(FY 2022)
- Ebitda -41.70%
(FY 2022)
- Net Worth 304.06%
(FY 2022)
- Total Assets 0.15%
(FY 2022)
About Anideep Eye Hospital And Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹26.58 Cr.
Anila Sawant and Swapnesh Deepak serve as directors at the Company.
- CIN/LLPIN
U85300MH2011PTC215540
- Company No.
215540
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 2011
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Anideep Eye Hospital And Institute?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anila Sawant  | Director | 15-Jun-2011 | Current |
| Swapnesh Deepak | Director | 30-Mar-2011 | Current |
Financial Performance of Anideep Eye Hospital And Institute.
Anideep Eye Hospital And Institute Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 41.56% increase. The company also saw a substantial improvement in profitability, with a 182.47% increase in profit. The company's net worth Soared by an impressive increase of 304.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anideep Eye Hospital And Institute?
Unlock access to Anideep Eye Hospital And Institute's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Bharat Co-Operative Bank (Mumbai) Ltd Creation Date: 30 May 2015 | ₹3.50 Cr | Open |
The Bharat Co-Operative Bank(Mumbai) Ltd Creation Date: 26 Dec 2013 | ₹5.00 Cr | Open |
The Bharat Co-Operative Bank (Mumbai) Ltd Creation Date: 27 Jun 2011 | ₹18.08 Cr | Open |
How Many Employees Work at Anideep Eye Hospital And Institute?
Unlock and access historical data on people associated with Anideep Eye Hospital And Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anideep Eye Hospital And Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anideep Eye Hospital And Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
